Received: 5 April 2022
Accepted: 20 June 2022
First Online: 8 September 2022
: The present study was approved by our institutional review board (IRB). Consent to participate is not applicable.
: Consent to publish was obtained from all individual participants included in the study.
: N.M, T.C, V.S, C.S.S, and J.C.R have nothing to disclose. R.S owns stock or stock options in Intellijoint, Gauss Surgical, and PSI. R.S is also a paid consultant for Smith & Nephew and Intellijoint. C.M.L is an unpaid consultant for FundamentalVR.